Download poster

Download Poster. Files over 3MB may be slow to open. For best results, right-click and select "save as..." (1.6 MB)

Description

Introduction

Dabigatran, a direct thrombin inhibitor, is used for stroke risk reduction in non-valvular atrial fibrillation and for treatment and prevention of venous thromboembolism. Minor side effects include indigestion and stomach pain. Major life threatening bleeding occurs in up to 2% of patients and is largely attributed to gastrointestinal hemorrhage. Here, we describe a case of a dabigatran related diffuse alveolar hemorrhage (DAH) treated successfully with extracorporeal membrane oxygenation.

Publication Date

5-22-2018

Keywords

pulmonary hemorrhage, ECMO, ARDS

Disciplines

Cardiology | Critical Care | Medicine and Health Sciences | Pulmonology

Comments

Presented at the 2018 American Thoracic Society Conference

A Rare Case of Diffuse Alveolar Hemorrhage Secondary to Dabigatran Successfully Treated with Extracorporeal Membrane Oxygenation

Share

COinS